patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Hub Home

> Log In

Demo Video
Private Messages
Edit My Profile
View/Edit Portfolio

AGORACOM News Flash

AGORACOM WIRE - FRIDAY MAY 25TH, 2012

FOCUS METALS (TSXV:FMS) Changes Its Name to Focus Graphite Inc.

Aim to develop and manufacture the best technology graphite in the world
Additional shareholder value will come from investment in commercialized graphene through joint venture partner, Grafoid Inc.

Read More | *SPONSOR

INTERNATIONAL PBX VENTURES (TSX:PBX) Signs Copaquire Joint Venture Option Agreement - $90M Potential Payment Read More

AGORACOM Maintenance Alert: Friday Evening Downtime for About an Hour Read More

LOMIKO METALS (TSXV:LMR) Graphite and Zinc Price Outlook is Favourable Through 2013 Read More | *SPONSOR

Message: fwiw -

Reply New Message

« Prev Message Back To Forum Go to Threaded View Next Message »

emit

Rank: [?]

Vice President

Points: [?]

21380

Rating: [?]

Votes: 166 Score: 3.0

Currently 3.1/5 Stars.

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.

fwiw -

posted on Oct 20, 11 02:37PM (Log in to use the IP Check tool) ^[?]

Sure hope our PH results bring them back to life in this arena; their PAH is failing.

8-24-11, FREEDOM-C(2) Trial of Oral Treprostinil in Pulmonary Arterial Hypertension Does Not Meet Primary Endpoint

http://ir.unither.com/releases.cfm

And Can you believe this:

I wrote back saying, ''That makes no sense - I saw and read it in your PR section right after the deal.''

From:	Andy Fisher <Andy@unither.com> Add to Contacts
To:	"alertid@att.net" <alertid@att.net>

Thanks, but that was actually not our press release, so it wouldn't normally appear in our news section.

From: "donotreply@broadcast.shareholder.com" <donotreply@broadcast.shareholder.com>
Reply-To: "alertid@att.net" <alertid@att.net>
Date: Wed, 19 Oct 2011 18:55:34 -0400
To: Andrew Fisher <andy@unither.com>
Subject: Pluristem PR

#cg_msg_content { font-family:arial, helvetica, sans-serif;}#cg_msg_content h1 {font-size:14px;}#cg_msg_content p,#cg_msg_content ul,#cg_msg_content td,#cg_msg_content th {font-size:12px;text-align:left;}#cg_msg_content small{font:10px Verdana;color:#ccc;}#cg_msg_content a{font-size:12px;text-align:left;}

The following comment was submitted via the United Therapeutics Corporation website by tim [alertid@att.net].

Your News section is missing the June 30 2011 PR with Pluristem.

Respectfully,

United Therapeutics Corporation
1040 Spring Street
Silver Spring, MD 20910

Reply New Message

« Prev Message Back To Forum Go to Threaded View Next Message »

New Message

Please login to post a reply

Agoracom TV

Check out Agoracom's daily, fast-paced, newscast on the morning's top Small-Cap newsmakers

Mesh With Us On The Web's Top Social Networking Sites

Find Our Content Throughout The Web With Our New Media Partners

AGORACOM Quick Tips

Small & Micro Cap 2.0 Blog by AGORACOM Members Read It Now

Click To Watch Today's Show

President's D.D.

5-9-12, Pluristem's PLX Cells Saves the Life of a Child after Bone Marrow Transplantation Failure.

4-17-12, Pluristem Receives U.S. FDA Clearance for Phase II Clinical Trial for the treatment of peripheral artery disease (PAD). read more

Stock Quote

Open PSTI Stock Quote

Investment Ideas

Like Pluristem Life Systems, Inc.? Then you might also be interested in Star Navigation Systems Group Ltd.

Star Navigation Systems Group Ltd.

Developer of the TERRASTARTM in-flight safety monitoring system
The first system in the world to feature real-time in-flight data monitoring and diagnostics
echnical Partnership Agreement with Astrium, a wholly owned subsidiary of EADS